ArticleFrontiers in aging2025
The curvilinear associations between Life's Crucial 9 and frailty: cross-sectional study of NHANES 2003 - 2023.
Article in Frontiers in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Frailty not only affects disease survival rates but also the quality of life. The Life's Crucial 9 (LC9) is a recently proposed cardiovascular health risk score that incorporates mental health along with Life's Essential 8 (LE8). The association between LC9 and frailty has not yet been reported. This study aims to explore the link between LC9 scores and levels of frailty. Methods: We used a weighted multiple logistic regression model to evaluate the relationship between Life's Essential 8 (LE8) and LC9 with frailty, and conducted trend tests to assess the stability of this association. Additionally, we employed smooth curve fitting to explore the potential curvilinear relationship between LE8 and LC9 with frailty. To identify inflection points, we applied recursive partitioning algorithms in conjunction with a two-stage linear regression model. Stratified analyses were performed to examine heterogeneity within various populations. Results: Our study included a total of 28,557 participants. In the regression model that accounted for all covariates, the odds ratios (ORs) for the association of LE8 and LC9 scores with frailty were 0.95 (95% CI: 0.94, 0.95) and 0.93 (95% CI: 0.93, 0.93), respectively, indicating a significantly stronger negative correlation with LC9 scores. Sensitivity analysis confirmed the robustness of this relationship. Smooth curve fitting revealed a nonlinear correlation between LE8 and LC9 scores and the degree of frailty. Further analysis using a two-piecewise linear regression model identified inflection points at 53.12 for LE8 and 68.89 for LC9. Below these thresholds, both LE8 and LC9 demonstrated a significant negative association with frailty. However, above these points, the strength of the negative correlation was somewhat reduced but remained statistically significant. In stratified analyses, both LE8 and LC9 exhibited significant negative associations with frailty, with LC9 showing a more pronounced relationship. Significant interaction effect was detected within the education level groups. Conclusion: We found a curvilinear relationship between LE8, LC9 and frailty, and the relationship between LC9 and frailty was more significant. This implies that LC9 can facilitate the early and precise identification of individuals at high risk of frailty, thereby providing a foundation for the development of targeted intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.